IBM tell pharma: Having a presence on social media sites is not equivalent to ‘using social media’

IBM’s recommendations to pharma include:

* Provide more information on drugs, medication and supporting services to a targeted audience

* Provide information about research on new drugs to the general community

* Educate the community about health issues/awareness and treatment

* Deepen the connection with groups of patients and healthcare professionals through unbranded presences

* Provide information on drug recalls more rapidly and to a wider audience than currently is the case